Replication/NN
of/IN
Interactions/NNS
between/IN
Genome-Wide/NN
Genetic/JJ
Variants/NNS
and/CC
Body/NN
Mass/NN
Index/NN
in/IN
Fasting/JJ
Glucose/NN
and/CC
Insulin/NN
Levels/NNS
./.
====================
The/DT
genetic/JJ
regulation/NN
of/IN
glucose/NN
and/CC
insulin/NN
levels/NNS
might/MD
be/VB
modified/VBN
by/IN
adiposity/NN
./.
====================
With/IN
regard/NN
to/TO
the/DT
genetic/JJ
factors/NNS
that/WDT
are/VBP
altered/JJ
by/IN
adiposity/NN
,/,
a/DT
large/JJ
meta-analysis/NN
on/IN
the/DT
interactions/NNS
between/IN
genetic/JJ
variants/NNS
and/CC
body/NN
mass/NN
index/NN
with/IN
regard/JJ
to/TO
fasting/JJ
glucose/NN
and/CC
insulin/NN
levels/NNS
was/VBD
reported/VBN
by/IN
the/DT
Meta-Analyses/NNS
of/IN
Glucose-/NN
and/CC
Insulin-related/JJ
trait/VBP
Consortium/NN
(/(
MAGIC/NN
)/)
,/,
based/VBN
on/IN
European/JJ
ancestry/NN
./.
====================
Because/IN
no/DT
replication/NN
study/NN
has/VBZ
been/VBN
performed/VBN
in/IN
other/JJ
ethnic/JJ
groups/NNS
,/,
we/PRP
first/RB
examined/VBN
the/DT
link/NN
between/IN
reported/VBN
single-nucleotide/IN
polymorphisms/NNS
(/(
SNPs/NNS
)/)
and/CC
fasting/JJ
glucose/NN
and/CC
insulin/NN
levels/NNS
in/IN
a/DT
large/JJ
Korean/JJ
cohort/JJ
(/(
Korean/JJ
Genome/NN
and/CC
Epidemiology/JJ
Study/NN
cohort/JJ
[/(
KoGES/NN
]/)
,/,
n/NN
=/JJ
5,814/CD
)/)
./.
====================
The/DT
MAGIC/NN
study/NN
reported/VBD
7/CD
novel/JJ
SNPs/NNS
for/IN
fasting/JJ
glucose/NN
levels/NNS
and/CC
6/CD
novel/JJ
SNPs/NNS
for/IN
fasting/JJ
insulin/NN
levels/NNS
./.
====================
In/IN
this/DT
study/NN
,/,
we/PRP
attempted/VBD
to/TO
replicate/VB
the/DT
association/NN
of/IN
5/CD
SNPs/NNS
with/IN
fasting/JJ
glucose/NN
levels/NNS
and/CC
5/CD
SNPs/NNS
with/IN
fasting/JJ
insulin/NN
levels/NNS
./.
====================
One/CD
SNP/NN
(/(
rs2293941/NN
)/)
in/IN
PDX1/NN
was/VBD
identified/VBN
as/IN
a/DT
significant/JJ
obesity-modifiable/JJ
factor/NN
in/IN
Koreans/NNS
./.
====================
Our/PRP$
results/NNS
indicate/VBP
that/IN
the/DT
novel/JJ
loci/NNS
that/IN
were/VBD
identified/VBN
by/IN
MAGIC/NN
are/VBP
poorly/RB
replicated/VBN
in/IN
other/JJ
ethnic/JJ
groups/NNS
,/,
although/IN
we/PRP
do/VBP
not/RB
know/VB
why/WRB
./.
====================
The/DT
rapid/JJ
socioeconomic/JJ
developments/NNS
in/IN
developing/VBG
countries/NNS
have/VBP
led/VBN
to/TO
a/DT
shift/NN
in/IN
infrastructure/JJ
,/,
technology/NN
,/,
and/CC
food/NN
supply/RB
,/,
promoting/VBG
overnutrition/NN
and/CC
sedentary/JJ
lifestyles/NNS
[/(
1/CD
]/)
./.
====================
Consequently/RB
,/,
the/DT
prevalence/NN
of/IN
metabolic/JJ
diseases/NNS
,/,
such/JJ
as/IN
obesity/NN
and/CC
type/NN
2/CD
diabetes/NNS
,/,
has/VBZ
risen/NN
dramatically/RB
[/(
2/CD
,/,
3/CD
]/)
./.
====================
In/IN
particular/JJ
,/,
Asian/JJ
countries/NNS
have/VBP
experienced/VBN
a/DT
notable/JJ
increase/VBP
in/IN
metabolic/JJ
disease/NN
;/:
thus/RB
,/,
prevention/NN
and/CC
control/NN
of/IN
metabolic/JJ
diseases/NNS
should/MD
be/VB
the/DT
top/NN
public/JJ
health/NN
priorities/NNS
in/IN
Asian/JJ
populations/NNS
[/(
3/CD
]/)
./.
====================
Glucose/NN
and/CC
insulin/NN
levels/NNS
after/IN
overnight/JJ
fasting/JJ
are/VBP
important/JJ
indicators/NNS
of/IN
glucose/NN
tolerance/NN
,/,
insulin/NN
resistance/NN
,/,
and/CC
type/NN
2/CD
diabetes/NNS
[/(
4/CD
]/)
./.
====================
Adiposity/NN
is/VBZ
believed/VBN
modulate/VBP
the/DT
genetic/JJ
determinants/NNS
of/IN
fasting/JJ
glucose/NN
and/CC
insulin/NN
levels/NNS
[/(
5/CD
]/)
./.
====================
To/TO
identify/VB
genetic/JJ
determinants/NNS
that/IN
could/MD
be/VB
modified/VBN
by/IN
body/NN
mass/NN
index/NN
(/(
BMI/NN
)/)
,/,
the/DT
interactions/NNS
between/IN
genome-wide/NN
single-nucleotide/JJ
polymorphisms/NNS
(/(
SNPs/NNS
)/)
and/CC
BMI/NN
with/IN
regard/JJ
to/TO
fasting/JJ
glucose/NN
and/CC
insulin/NN
levels/NNS
were/VBD
analyzed/VBN
by/IN
the/DT
Meta-Analyses/NNS
of/IN
Glucose-/NN
and/CC
Insulin-related/JJ
traits/VBZ
Consortium/NN
(/(
MAGIC/NN
)/)
[/(
6/CD
]/)
./.
====================
MAGIC/NN
identified/VBD
several/JJ
novel/JJ
genetic/JJ
variants/NNS
:/:
7/CD
SNPs/NNS
(/(
ARAP1/NN
,/,
FOXA2/NN
,/,
DPYSL5/NN
,/,
PCSK1/NN
,/,
PDX1/NN
,/,
PPP1R3B/NN
,/,
and/CC
OR4S1/NN
)/)
for/IN
fasting/JJ
glucose/NN
level/NN
and/CC
6/CD
SNPs/NNS
(/(
COBLL1-GRB14/NN
,/,
IRS1/NN
,/,
PPP1R3B/NN
,/,
PDGFC/NN
,/,
UHRF1BP1/NN
,/,
and/CC
LYPLAL1/NN
)/)
for/IN
fasting/JJ
insulin/NN
level/NN
[/(
6/CD
]/)
./.
====================
The/DT
MAGIC/NN
study/NN
comprised/VBD
approximately/RB
70,000/CD
nondiabetic/JJ
individuals/NNS
of/IN
European/JJ
ancestry/NN
,/,
and/CC
its/PRP$
results/NNS
should/MD
be/VB
confirmed/VBN
in/IN
other/JJ
ethnic/JJ
groups/NNS
[/(
7/CD
]/)
./.
====================
Because/IN
no/DT
replication/NN
study/NN
has/VBZ
been/VBN
performed/VBN
in/IN
other/JJ
ethnicities/NNS
,/,
we/PRP
examined/VBD
these/DT
SNPs/NNS
and/CC
their/PRP$
association/NN
with/IN
fasting/JJ
glucose/NN
and/CC
insulin/NN
levels/NNS
and/CC
determined/VBN
whether/IN
they/PRP
are/VBP
modified/VBN
by/IN
obesity/NN
in/IN
the/DT
Korean/JJ
population/NN
./.
====================
The/DT
study/NN
design/NN
can/MD
be/VB
found/VBN
in/IN
Fig/NN
./.
====================
1/CD
./.
====================
Study/NN
subjects/NNS
and/CC
genotypes/NNS
====================
The/DT
subjects/NNS
and/CC
their/PRP$
genotypes/NNS
in/IN
the/DT
original/JJ
study/NN
have/VBP
been/VBN
reported/VBN
[/(
7/CD
]/)
./.
====================
The/DT
initial/JJ
subjects/NNS
were/VBD
obtained/VBN
from/IN
a/DT
subset/NN
of/IN
the/DT
Korean/JJ
Genome/NN
and/CC
Epidemiology/JJ
Study/NN
cohort/NN
(/(
KoGES/NN
)/)
,/,
known/VBN
as/IN
Korean/JJ
Association/NN
Resource/NN
(/(
KARE/NN
,/,
n/NN
=/JJ
8,842/CD
)/)
[/(
7/CD
]/)
./.
====================
Written/RB
informed/VBN
consent/NN
was/VBD
obtained/VBN
from/IN
all/DT
participants/NNS
,/,
and/CC
this/DT
project/JJ
was/VBD
approved/VBN
by/IN
the/DT
institutional/JJ
review/NN
board/IN
at/IN
Korea/NN
National/JJ
Institute/JJ
of/IN
Health/NN
(/(
KNIH/NN
)/)
./.
====================
Phenotypes/NNS
and/CC
quantitative/JJ
traits/VBZ
====================
Past/NN
diabetes/NNS
history/JJ
was/VBD
obtained/VBN
through/IN
structured/JJ
questionnaires/NNS
by/IN
interviewers/NNS
./.
====================
Anthropometric/JJ
measurements/NNS
,/,
including/VBG
weight/NN
and/CC
height/RB
,/,
were/VBD
also/RB
obtained/VBN
,/,
and/CC
BMI/NN
was/VBD
calculated/VBN
as/IN
weight/NN
(/(
kg/NN
)/)
/height/NN
(/(
m2/NN
)/)
[/(
2/CD
]/)
./.
====================
Biochemical/JJ
assessments/NNS
were/VBD
performed/VBN
,/,
including/VBG
fasting/JJ
serum/NN
glucose/NN
,/,
2-h/JJ
75/CD
g/NN
oral/JJ
glucose/NN
tolerance/NN
test/NN
,/,
and/CC
fasting/JJ
serum/NN
insulin/NN
(/(
FSI/NN
)/)
./.
====================
A/DT
total/JJ
of/IN
3,028/CD
subjects/NNS
with/IN
prevalent/JJ
hyperglycemia/NN
(/(
fasting/JJ
glucose/NN
≥/NN
110/CD
,/,
2-h/JJ
glucose/NN
level/NN
after/IN
75/CD
g/NN
oral/JJ
glucose/NN
challenge/NN
≥/CD
140/CD
)/)
,/,
or/CC
self-reported/JJ
diabetes/NNS
history/JJ
were/VBD
excluded/VBN
./.
====================
Of/IN
the/DT
8,842/CD
individuals/NNS
who/WP
were/VBD
examined/VBN
in/IN
the/DT
previous/JJ
genomewide/NN
association/NN
study/NN
[/(
7/CD
]/)
,/,
5,814/CD
nondiabetic/JJ
individuals/NNS
were/VBD
selected/VBN
./.
====================
SNP/NN
genotypes/NNS
====================
The/DT
genotypes/NNS
were/VBD
obtained/VBN
using/VBG
the/DT
Affymetrix/JJ
Genome-Wide/NN
Human/JJ
SNP/NN
array/NN
5.0/CD
(/(
Affymetrix/JJ
Inc./NNP
,/,
Santa/NN
Clara/NN
,/,
CA/NN
,/,
USA/NN
)/)
./.
====================
The/DT
genotype/NN
quality/NN
control/NN
criteria/NNS
have/VBP
been/VBN
reported/VBN
in/IN
a/DT
previous/JJ
genome-wide/NN
association/NN
study/NN
[/(
7/CD
]/)
./.
====================
Briefly/RB
,/,
every/RB
500/CD
ng/NN
of/IN
genomic/JJ
DNA/NN
was/VBD
genotyped/VBN
on/IN
the/DT
Affy/JJ
5.0/CD
,/,
and/CC
the/DT
Bayesian/JJ
robust/JJ
linear/JJ
genotyping/VBG
algorithm/NN
using/VBG
Mahalanobis/NN
distance/NN
was/VBD
used/VBN
for/IN
genotype/NN
calling/JJ
[/(
8/CD
]/)
./.
====================
Samples/NNS
with/IN
a/DT
high/JJ
missing/VBG
genotype/NN
call/JJ
rate/NN
(/(
≥4/CD
%/NN
)/)
,/,
high/JJ
heterozygosity/NN
(/(
>/JJR
30/CD
%/NN
)/)
,/,
inconsistency/NN
in/IN
sex/NN
,/,
and/CC
any/DT
tumor/NN
were/VBD
excluded/VBN
from/IN
subsequent/JJ
analyses/NNS
./.
====================
Genotype/NN
imputation/NN
====================
Of/IN
the/DT
13/CD
SNPs/NNS
that/DT
were/VBD
reported/VBN
by/IN
the/DT
MAGIC/NN
consortium/NN
,/,
4/CD
SNPs/NNS
were/VBD
genotyped/VBN
in/IN
the/DT
original/JJ
KARE/NN
genotype/NN
data/NNS
using/VBG
the/DT
Affy/JJ
5.0/CD
./.
====================
To/TO
maximize/VB
the/DT
validation/NN
SNPs/NNS
in/IN
Koreans/NNS
,/,
the/DT
Chinese-Japanese/JJ
HapMap/NN
dataset/NN
was/VBD
imputed/VBN
to/TO
obtain/VB
6/CD
additional/JJ
SNPs/NNS
./.
====================
Thus/RB
,/,
10/CD
SNPs/NNS
were/VBD
analyzed/VBN
in/IN
this/DT
study/NN
./.
====================
The/DT
detailed/JJ
imputation/NN
procedure/NN
has/VBZ
been/VBN
published/VBN
./.
====================
Briefly/RB
,/,
the/DT
KARE/NN
dataset/NN
,/,
comprising/VBG
351,677/CD
SNPs/NNS
in/IN
8,842/CD
individuals/NNS
,/,
was/VBD
merged/VBN
with/IN
that/DT
of/IN
the/DT
international/JJ
HapMap/NN
Phase/NN
II/CD
Japanese/JJ
(/(
JPT/NN
)/)
+/CC
Chinese/JJ
(/(
HCB/NN
)/)
panel/NN
2/CD
[/(
9/CD
]/)
./.
====================
The/DT
genotypes/NNS
of/IN
the/DT
KARE/NN
individuals/NNS
were/VBD
imputed/VBN
using/VBG
IMPUTE/NN
[/(
10/CD
]/)
./.
====================
Using/VBG
the/DT
following/VBG
filtering/VBG
scheme-INFO/NN
≥/CD
0.5/CD
and/CC
posterior/JJ
probability/NN
≥/CD
0.9-1,827,004/CD
SNPs/NNS
were/VBD
imputed/VBN
,/,
and/CC
6/CD
SNPs/NNS
that/DT
matched/VBN
among/IN
the/DT
13/CD
SNPs/NNS
that/DT
were/VBD
reported/VBN
by/IN
MAGIC/NN
were/VBD
selected/VBN
for/IN
study/NN
./.
====================
Statistical/JJ
analysis/NN
====================
Glucose/NN
and/CC
insulin/NN
levels/NNS
were/VBD
natural/JJ
log-transformed/VBD
./.
====================
To/TO
examine/VB
the/DT
effects/NNS
of/IN
SNP-BMI/NN
interactions/NNS
on/IN
them/PRP
,/,
we/PRP
conducted/VBD
4/CD
statistical/JJ
tests/NNS
for/IN
each/DT
SNP/NN
./.
====================
In/IN
all/DT
analyses/NNS
,/,
residential/JJ
area/NN
,/,
age/NN
,/,
sex/NN
,/,
and/CC
BMI/NN
were/VBD
the/DT
covariates/NNS
./.
====================
The/DT
first/JJ
2/CD
tests/NNS
were/VBD
linear/JJ
regression/NN
analyses/NNS
of/IN
lean/JJ
(/(
BMI/NN
</JJR
25/CD
)/)
and/CC
overweight/JJ
subjects/NNS
(/(
BMI/NN
≥/CD
25/CD
)/)
./.
====================
The/DT
overall/JJ
interactions/NNS
between/IN
SNPs/NNS
and/CC
BMI/NN
were/VBD
analyzed/VBN
using/VBG
continuous/JJ
BMI/NN
values/NNS
and/CC
dichotomized/VBD
BMI/NN
(/(
lean/JJ
subjects/NNS
were/VBD
coded/VBN
with/IN
1/CD
,/,
and/CC
overweight/IN
subjects/NNS
were/VBD
coded/VBN
with/IN
2/CD
)/)
./.
====================
Continuous/JJ
BMI-SNP/NN
interaction/NN
analyses/NNS
were/VBD
performed/VBN
using/VBG
QUICKTEST/NN
(/(
http/NN
:/:
//toby.freeshell.org/software/quicktest.shtml/NN
)/)
,/,
and/CC
the/DT
dichotomized/VBN
BMI-SNP/NN
interactions/NNS
were/VBD
analyzed/VBN
using/VBG
PLINK/NN
,/,
version/NN
1.07/CD
[/(
11/CD
]/)
./.
====================
The/DT
fasting/JJ
serum/NN
glucose/NN
and/CC
insulin/NN
levels/NNS
of/IN
our/PRP$
subjects/NNS
are/VBP
shown/VBN
in/IN
Table/JJ
1/CD
./.
====================
We/PRP
divided/VBD
subjects/NNS
into/IN
4/CD
groups/NNS
,/,
based/VBN
on/IN
BMI/NN
;/:
most/JJS
Korean/JJ
subjects/NNS
lay/NN
in/IN
the/DT
20/CD
≤/NN
BMI/NN
</JJR
25/CD
and/CC
25/CD
≤/NN
BMI/NN
</JJR
30/CD
categories/NNS
./.
====================
The/DT
MAGIC/NN
study/NN
had/VBD
BMI/NN
cutoffs/NNS
of/IN
</JJR
25/CD
and/CC
≥/NN
30/CD
,/,
and/CC
237/CD
of/IN
our/PRP$
subjects/NNS
(/(
4/CD
%/NN
)/)
had/VBD
BMI/NN
≥/CD
30/CD
./.
====================
Asians/NNS
have/VBP
lower/JJR
rates/NNS
of/IN
overweightedness/JJ
and/CC
obesity/NN
than/IN
Western/NN
populations/NNS
,/,
per/IN
conventional/JJ
definitions/NNS
(/(
BMI/NN
≥/CD
25/CD
for/IN
overweightedness/JJ
and/CC
≥/NN
30/CD
for/IN
obesity/NN
)/)
[/(
3/CD
]/)
./.
====================
Despite/IN
having/VBG
lower/JJR
BMIs/NNS
,/,
Asian/JJ
countries/NNS
have/VBP
a/DT
similar/JJ
or/CC
greater/JJR
prevalence/NN
of/IN
diabetes/NNS
versus/CC
Western/NN
countries/NNS
[/(
12/CD
]/)
./.
====================
Thus/RB
,/,
we/PRP
used/VBD
BMI/NN
</JJR
25/CD
and/CC
BMI/NN
≥/CD
25/CD
to/TO
analyze/VB
the/DT
effects/NNS
of/IN
SNPs/NNS
and/CC
SNP-dichotomized/JJ
BMI/NN
interactions/NNS
by/IN
stratum/NN
./.
====================
Of/IN
the/DT
6/CD
SNPs/NNS
that/DT
were/VBD
associated/VBN
with/IN
FSI/NN
levels/NNS
in/IN
the/DT
MAGIC/NN
studies/NNS
,/,
5/CD
SNPs/NNS
could/MD
be/VB
tested/VBN
in/IN
the/DT
current/JJ
study/NN
,/,
and/CC
no/DT
SNP/NN
was/VBD
replicated/VBN
in/IN
all/DT
3/CD
statistical/JJ
tests/NNS
(/(
stratified/JJ
BMI/NN
,/,
continuous/JJ
BMI/NN
interaction/NN
p-values/NNS
,/,
and/CC
dichotomized/VBD
BMI/NN
interaction/NN
p-values/NNS
)/)
(/(
see/VB
Table/JJ
2/CD
)/)
./.
====================
Of/IN
the/DT
7/CD
reported/VBD
SNPs/NNS
that/IN
were/VBD
linked/VBN
to/TO
fasting/JJ
plasma/NN
glucose/NN
levels/NNS
,/,
5/CD
SNPs/NNS
could/MD
be/VB
tested/VBN
in/IN
the/DT
current/JJ
study/NN
,/,
and/CC
1/CD
SNP/NN
(/(
rs2293941/NN
)/)
in/IN
pancreatic/JJ
and/CC
duodenal/JJ
homeobox/NN
1/CD
(/(
PDX1/NN
)/)
was/VBD
significantly/RB
associated/VBN
in/IN
lean/JJ
subjects/NNS
(/(
beta/NN
±/CD
SE/NN
,/,
0.007/CD
±/NNP
0.002/CD
;/:
p/NN
=/JJ
0.001/CD
)/)
but/CC
not/RB
in/IN
overweight/JJ
subjects/NNS
./.
====================
The/DT
SNP-continuous/JJ
BMI/NN
interaction/NN
was/VBD
not/RB
significant/JJ
,/,
but/CC
the/DT
SNP-dichotomized/JJ
BMI/NN
interaction/NN
was/VBD
marginal/JJ
(/(
p/NN
=/JJ
0.04/CD
)/)
./.
====================
Our/PRP$
results/NNS
indicate/VBP
that/IN
the/DT
novel/JJ
loci/NNS
that/IN
were/VBD
identified/VBN
by/IN
MAGIC/NN
are/VBP
poorly/RB
replicated/VBN
in/IN
other/JJ
ethnic/JJ
groups/NNS
,/,
although/IN
we/PRP
do/VBP
not/RB
know/VB
why/WRB
./.
====================
We/PRP
have/VBP
identified/VBN
an/DT
important/JJ
genetic/JJ
factor/NN
of/IN
glucose/NN
metabolism/NN
,/,
PDX1/NN
,/,
which/WDT
regulates/VBZ
pancreatic/JJ
beta-cell/NN
function/NN
and/CC
survival/NN
by/IN
governing/VBG
expression/NN
of/IN
the/DT
insulin-encoding/JJ
INS/NN
gene/NN
[/(
13/CD
]/)
./.
====================
This/DT
study/NN
was/VBD
limited/VBN
by/IN
its/PRP$
exclusion/NN
of/IN
3/CD
other/JJ
SNP-BMI/NN
interactions/NNS
from/IN
MAGIC/NN
./.
====================
These/DT
SNPs/NNS
could/MD
not/RB
be/VB
extracted/VBN
from/IN
the/DT
imputation/NN
data/NNS
using/VBG
the/DT
original/JJ
Affy/JJ
5.0/CD
in/IN
the/DT
KARE/NN
study/NN
./.
====================
Another/DT
limitation/NN
of/IN
this/DT
study/NN
was/VBD
the/DT
relatively/RB
weak/JJ
significance/NN
of/IN
its/PRP$
association/NN
results/NNS
compared/VBD
with/IN
those/DT
of/IN
MAGIC/NN
./.
====================
We/PRP
do/VBP
not/RB
know/VB
whether/IN
this/DT
lack/NN
of/IN
significance/NN
is/VBZ
due/JJ
to/TO
the/DT
relatively/RB
smaller/JJR
sample/NN
size/NN
of/IN
this/DT
study/NN
compared/VBD
with/IN
MAGIC/NN
,/,
the/DT
inaccuracy/NN
of/IN
imputation/NN
genotypes/NNS
,/,
or/CC
ethnic/JJ
differences/NNS
in/IN
the/DT
SNP-BMI/NN
interactions/NNS
./.
====================
These/DT
issues/NNS
should/MD
be/VB
addressed/VBN
in/IN
other/JJ
Asian/JJ
populations/NNS
./.
====================
Although/IN
the/DT
replication/NN
of/IN
gene-environment/JJ
interactions/NNS
in/IN
other/JJ
ethnic/JJ
groups/NNS
is/VBZ
difficult/JJ
,/,
interethnic/JJ
conservation/NN
of/IN
the/DT
interaction/NN
results/VBZ
might/MD
help/VB
us/PRP
determine/VBP
the/DT
underlying/VBG
mechanisms/NNS
of/IN
the/DT
target/NN
phenotypes/NNS
./.
====================
Further/RB
,/,
the/DT
rs2293941/NN
SNP/NN
might/MD
help/VB
us/PRP
understand/VB
individual/JJ
differences/NNS
in/IN
beta-cell/NN
function/NN
./.
====================
Schematic/JJ
of/IN
the/DT
study/NN
design/NN
./.
====================
SNP/NN
,/,
single-nucleotide/JJ
polymorphism/NN
;/:
BMI/NN
,/,
body/NN
mass/NN
index/NN
;/:
MAGIC/NN
,/,
Meta-Analysis/NN
of/IN
Glucose/NN
and/CC
Insulin/NN
Consortium/NN
;/:
KARE/NN
,/,
Korean/JJ
Association/NN
Resource/NN
consortium/NN
./.
====================
Clinical/JJ
characteristics/NNS
====================
Replication/NN
results/NNS
of/IN
MAGIC-reported/JJ
SNPs/NNS
for/IN
fasting/JJ
insulin/NN
levels/NNS
and/CC
fasting/JJ
glucose/NN
levels/NNS
====================
